Thrilled to announce a new partnership between reach52 and Amgen, focusing on Cardiometabolic Syndrome (CMS) in underserved communities in the Philippines
CMS is a combination of metabolic dysfunctions mainly characterised by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity. 23.6% of Filipinos aged 40-59 and 24.1% of those 60 years and older are affected by CMS.
Throughout this campaign, we invite you to join us as we share an inside peek: from interviews and insights on-the-ground to better understand community needs, to how local Community Health Agents use the offline-first reach52 access app to conduct door-to-door engagements with residents, delivering personalised health tips.
Through these targeted engagements, we aim to help residents and their caregivers understand CMS, and identify lifestyle modifications, early screening, risk assessment, and treatment options. A unique component of this campaign includes a focus on the role of caregivers and ensuring a strong support system.
Follow us as we embark on this exciting journey using data-driven, human-powered tech to improve health outcomes surrounding CMS in underserved communities in the Philippines. Stay tuned for our next update!